Skip to main content
InnoCan Pharma Corporation logo

InnoCan Pharma Corporation — Investor Relations & Filings

Ticker · INNO LEI · 54930034HVBO62OM7178 CSE Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2026-04-06 Regulatory Filings
Country CA Canada
Listing CSE INNO

About InnoCan Pharma Corporation

https://innocanpharma.com/

InnoCan Pharma Corporation is a pharmaceutical technology company focused on developing innovative drug delivery platforms that utilize cannabinoids, primarily cannabidiol (CBD), to create novel therapeutics. The company specializes in advanced delivery systems designed to harness the healing properties of these compounds. A core development is the CBD-loaded liposome drug delivery system (LPT), which is being investigated as a sustained-release, non-opioid analgesic approach for chronic pain management. InnoCan operates across the pharmaceuticals and wellness sectors, aiming to provide improved medical solutions through cannabinoid-based technology.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Form 45-106F1 “Report of Exempt Distribution,” which is a Canadian securities regulatory filing detailing the particulars of a prospectus-exempt securities distribution. It is not an annual or interim financial report, earnings release, management presentation, or any of the specific corporate event notices listed. It is a mandated regulatory disclosure form falling outside other defined categories, thus the fallback “Regulatory Filings” (RNS) best applies.
2026-04-06 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Form 51-102F3 Material Change Report notifying of the closing of a debenture offering for gross proceeds of US $200,000. This constitutes a financing activity (company fundraising and capital structure change). It is not an interim or annual report, nor just an announcement of a report. It is a direct financing update. Therefore, it fits the Capital/Financing Update category.
2026-04-06 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Form 45-106F1 “Report of Exempt Distribution,” a mandatory Canadian securities regulatory filing detailing an exempt distribution under NI 45-106. It is not an earnings announcement, annual or interim report, management discussion, or other corporate presentation, nor is it simply announcing publication of a report. This type of compliance disclosure falls under the generic “Regulatory Filings” category (Code: RNS).
2026-04-06 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Form 51-102F3 Material Change Report filed under Canadian continuous disclosure rules. It announces the closing of a debt financing (an offering of a debenture for US$200,000) to a related party, including terms, interest rate, maturity, and reliance on MI 61-101 exemptions. This is a financing activity update rather than an annual report, management change, or earnings release. Therefore it is best classified as a Capital/Financing Update.
2026-04-06 English
News release - English.pdf
M&A Activity Classification · 0% confidence The document is a news release announcing that Altura Energy has finalized a farm-in agreement to acquire development rights over 2,560 acres of helium acreage. This is not an earnings release, dividend notice, management change, nor a regulatory financial report. It describes an asset acquisition partnership (a farm-in), which falls under corporate transaction announcements. The most appropriate category in our taxonomy for such strategic asset acquisition announcements is M&A Activity (Code: TAR).
2026-04-06 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a company news release announcing the closing of an additional debenture financing, providing details on the terms, related party nature, and proceeds application. This is clearly a financing activity update rather than a regular earnings release or regulatory filing of financial statements. It fits our definition of Capital/Financing Update (CAP).
2026-04-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.